147 related articles for article (PubMed ID: 28461099)
61. Therapeutic efficacy evaluation of 111In-labeled PEGylated liposomal vinorelbine in murine colon carcinoma with multimodalities of molecular imaging.
Chow TH; Lin YY; Hwang JJ; Wang HE; Tseng YL; Pang VF; Liu RS; Lin WJ; Yang CS; Ting G
J Nucl Med; 2009 Dec; 50(12):2073-81. PubMed ID: 19949027
[TBL] [Abstract][Full Text] [Related]
62. Direct comparison of liposomal doxorubicin with or without polyethylene glycol coating in C-26 tumor-bearing mice: is surface coating with polyethylene glycol beneficial?
Hong RL; Huang CJ; Tseng YL; Pang VF; Chen ST; Liu JJ; Chang FH
Clin Cancer Res; 1999 Nov; 5(11):3645-52. PubMed ID: 10589782
[TBL] [Abstract][Full Text] [Related]
63. Lipid-based nanoparticles for siRNA delivery in cancer therapy: paradigms and challenges.
Gomes-da-Silva LC; Fonseca NA; Moura V; Pedroso de Lima MC; Simões S; Moreira JN
Acc Chem Res; 2012 Jul; 45(7):1163-71. PubMed ID: 22568781
[TBL] [Abstract][Full Text] [Related]
64. Self-crosslinked human serum albumin nanocarriers for systemic delivery of polymerized siRNA to tumors.
Son S; Song S; Lee SJ; Min S; Kim SA; Yhee JY; Huh MS; Chan Kwon I; Jeong SY; Byun Y; Kim SH; Kim K
Biomaterials; 2013 Dec; 34(37):9475-85. PubMed ID: 24050874
[TBL] [Abstract][Full Text] [Related]
65. Targeting ETS1 with RNAi-based supramolecular nanoassemblies for multidrug-resistant breast cancer therapy.
Wu M; Liu X; Jin W; Li Y; Li Y; Hu Q; Chu PK; Tang G; Ping Y
J Control Release; 2017 May; 253():110-121. PubMed ID: 28302581
[TBL] [Abstract][Full Text] [Related]
66. PEG-liposomal oxaliplatin induces apoptosis in human colorectal cancer cells via Fas/FasL and caspase-8.
Yang C; Liu HZ; Fu ZX
Cell Biol Int; 2012 Mar; 36(3):289-96. PubMed ID: 21888623
[TBL] [Abstract][Full Text] [Related]
67. Monoclonal antibody-targeted PEGylated liposome-ICG encapsulating doxorubicin as a potential theranostic agent.
Lozano N; Al-Ahmady ZS; Beziere NS; Ntziachristos V; Kostarelos K
Int J Pharm; 2015 Mar; 482(1-2):2-10. PubMed ID: 25445515
[TBL] [Abstract][Full Text] [Related]
68. Efficient suppression of murine arthritis by combined anticytokine small interfering RNA lipoplexes.
Khoury M; Escriou V; Courties G; Galy A; Yao R; Largeau C; Scherman D; Jorgensen C; Apparailly F
Arthritis Rheum; 2008 Aug; 58(8):2356-67. PubMed ID: 18668557
[TBL] [Abstract][Full Text] [Related]
69. Systemic delivery of siRNA by aminated poly(α)glutamate for the treatment of solid tumors.
Polyak D; Krivitsky A; Scomparin A; Eliyahu S; Kalinski H; Avkin-Nachum S; Satchi-Fainaro R
J Control Release; 2017 Jul; 257():132-143. PubMed ID: 27356019
[TBL] [Abstract][Full Text] [Related]
70. Anti-tumor activity of liposomal glucocorticoids: The relevance of liposome-mediated drug delivery, intratumoral localization and systemic activity.
Kluza E; Yeo SY; Schmid S; van der Schaft DW; Boekhoven RW; Schiffelers RM; Storm G; Strijkers GJ; Nicolay K
J Control Release; 2011 Apr; 151(1):10-7. PubMed ID: 21130819
[TBL] [Abstract][Full Text] [Related]
71. Metronomic 5-fluorouracil, oxaliplatin and irinotecan in colorectal cancer.
Fioravanti A; Canu B; Alì G; Orlandi P; Allegrini G; Di Desidero T; Emmenegger U; Fontanini G; Danesi R; Del Tacca M; Falcone A; Bocci G
Eur J Pharmacol; 2009 Oct; 619(1-3):8-14. PubMed ID: 19695243
[TBL] [Abstract][Full Text] [Related]
72. Pegylated liposome-encapsulated doxorubicin and cisplatin enhance the effect of radiotherapy in a tumor xenograft model.
Harrington KJ; Rowlinson-Busza G; Syrigos KN; Vile RG; Uster PS; Peters AM; Stewart JS
Clin Cancer Res; 2000 Dec; 6(12):4939-49. PubMed ID: 11156255
[TBL] [Abstract][Full Text] [Related]
73. S-Nitrosated human serum albumin dimer as novel nano-EPR enhancer applied to macromolecular anti-tumor drugs such as micelles and liposomes.
Kinoshita R; Ishima Y; Ikeda M; Kragh-Hansen U; Fang J; Nakamura H; Chuang VT; Tanaka R; Maeda H; Kodama A; Watanabe H; Maeda H; Otagiri M; Maruyama T
J Control Release; 2015 Nov; 217():1-9. PubMed ID: 26302904
[TBL] [Abstract][Full Text] [Related]
74. Secretory phospholipase A
Østrem RG; Parhamifar L; Pourhassan H; Clergeaud G; Nielsen OL; Kjær A; Hansen AE; Andresen TL
J Control Release; 2017 Sep; 262():212-221. PubMed ID: 28754610
[TBL] [Abstract][Full Text] [Related]
75. Preclinical Justification of pbi-shRNA EWS/FLI1 Lipoplex (LPX) Treatment for Ewing's Sarcoma.
Rao DD; Jay C; Wang Z; Luo X; Kumar P; Eysenbach H; Ghisoli M; Senzer N; Nemunaitis J
Mol Ther; 2016 Aug; 24(8):1412-22. PubMed ID: 27166877
[TBL] [Abstract][Full Text] [Related]
76. Trilysinoyl oleylamide-based cationic liposomes for systemic co-delivery of siRNA and an anticancer drug.
Shim G; Han SE; Yu YH; Lee S; Lee HY; Kim K; Kwon IC; Park TG; Kim YB; Choi YS; Kim CW; Oh YK
J Control Release; 2011 Oct; 155(1):60-6. PubMed ID: 20971142
[TBL] [Abstract][Full Text] [Related]
77. PEGylated dendritic diaminocyclohexyl-platinum (II) conjugates as pH-responsive drug delivery vehicles with enhanced tumor accumulation and antitumor efficacy.
Pan D; She W; Guo C; Luo K; Yi Q; Gu Z
Biomaterials; 2014 Dec; 35(38):10080-92. PubMed ID: 25263685
[TBL] [Abstract][Full Text] [Related]
78. Enhanced growth inhibition of hepatic multicellular tumor spheroids by lactosylated poly(ethylene glycol)-siRNA conjugate formulated in PEGylated polyplexes.
Oishi M; Nagasaki Y; Nishiyama N; Itaka K; Takagi M; Shimamoto A; Furuichi Y; Kataoka K
ChemMedChem; 2007 Sep; 2(9):1290-7. PubMed ID: 17546711
[TBL] [Abstract][Full Text] [Related]
79. Luminescent/magnetic PLGA-based hybrid nanocomposites: a smart nanocarrier system for targeted codelivery and dual-modality imaging in cancer theranostics.
Shen X; Li T; Chen Z; Geng Y; Xie X; Li S; Yang H; Wu C; Liu Y
Int J Nanomedicine; 2017; 12():4299-4322. PubMed ID: 28652734
[TBL] [Abstract][Full Text] [Related]
80. Targeting of pegylated liposomal mitomycin-C prodrug to the folate receptor of cancer cells: Intracellular activation and enhanced cytotoxicity.
Patil Y; Amitay Y; Ohana P; Shmeeda H; Gabizon A
J Control Release; 2016 Mar; 225():87-95. PubMed ID: 26809007
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]